Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States

Publisher： Karger

E-ISSN： 1423-0232|93|4|233-242

ISSN： 0030-2414

Source： Oncology, Vol.93, Iss.4, 2017-07, pp. : 233-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Study of Concurrent Chemoradiotherapy with S-1 for T2N0 Glottic Carcinoma

By  

Oncology, Vol. 71, Iss. 5-6, 2007-09 ,pp. : 369-373

Karger

Access to resources Recommend Favorite

Adjuvant Chemotherapy in the Management of pT3N0M0 Transitional Cell Carcinoma of the Upper Urinary Tract

By  

Urologia Internationalis, Vol. 77, Iss. 1, 2009-05 ,pp. : 22-26

Karger

Access to resources Recommend Favorite

Single-Agent Epirubicin as Primary Chemotherapy in T2–T3, N0–N2, M0 Breast Carcinoma: 6-Year Follow-Up

By  

Oncology, Vol. 67, Iss. 1, 2004-10 ,pp. : 40-47

Karger

Access to resources Recommend Favorite

Schmincke’s Tumor, Carcinoma of the Base of the Tongue c T1-2, cN2c M0 – A Case Report

By  

Case Reports in Oncology, Vol. 3, Iss. 1, 2010-03 ,pp. : 77-82

Karger

Access to resources Recommend Favorite

A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 662-675

John Wiley & Sons Inc

Access to resources Recommend Favorite